Annual Net Income
-$21.15 M
-$8.45 M-66.56%
September 1, 2024
Summary
- As of February 7, 2025, CTOR annual net profit is -$21.15 million, with the most recent change of -$8.45 million (-66.56%) on September 1, 2024.
- During the last 3 years, CTOR annual net income has fallen by -$15.72 million (-289.29%).
- CTOR annual net income is now -289.29% below its all-time high of -$5.43 million, reached on September 1, 2022.
Performance
CTOR Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
CTOR Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -66.6% | - | - |
| 3 y3 years | -289.3% | - | - |
| 5 y5 years | -289.3% | - | - |
CTOR Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -289.3% | at low | ||||
| 5 y | 5-year | -289.3% | at low | ||||
| alltime | all time | -289.3% | at low |
Citius Oncology Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | -$21.15 M(+66.6%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | -$12.70 M(+133.7%) | - | - |
| Sep 2022 | -$5.43 M | - | - |
FAQ
- What is Citius Oncology annual net profit?
- What is the all time high annual net income for Citius Oncology?
- What is Citius Oncology annual net income year-on-year change?
What is Citius Oncology annual net profit?
The current annual net income of CTOR is -$21.15 M
What is the all time high annual net income for Citius Oncology?
Citius Oncology all-time high annual net profit is -$5.43 M
What is Citius Oncology annual net income year-on-year change?
Over the past year, CTOR annual net profit has changed by -$8.45 M (-66.56%)